核医学/放射性医薬品の世界市場:種類別(診断核医学、治療核医学)、用途別(診断用、治療用)、処置別(診断、治療)、地域別

◆英語タイトル:Global Nuclear Medicine/ Radiopharmaceuticals Market Size study, by Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Application (Diagnostic Application and Therapeutic Application), by Procedural Volume (Diagnostic procedures and Therapeutic procedures) and Regional Forecasts 2019-2026
◆商品コード:BZW20AP048
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年2月4日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥650,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、核医学/放射性医薬品の世界市場について、エグゼクティブサマリー、市場の定義・範囲、市場動向、産業分析、種類別(診断核医学、治療核医学)分析、用途別(診断用、治療用)分析、処置別(診断、治療)分析、地域別分析、競争状況などを総合的、多面的に調査・分析しております。
・エグゼクティブサマリー
・市場の定義・範囲
・市場動向
・産業分析
・核医学/放射性医薬品の世界市場:種類別(診断核医学、治療核医学)
・核医学/放射性医薬品の世界市場:用途別(診断用、治療用)
・核医学/放射性医薬品の世界市場:処置別(診断、治療)
・核医学/放射性医薬品の世界市場:地域別
・競争状況
【レポートの概要】

Global Nuclear Medicine/ Radiopharmaceuticals Market is valued approximately at USD 3.95 Billion in 2018 and is anticipated to grow with a growth rate of more than 5.90% over the forecast period 2019-2026. Nuclear medicine is medical specialty that uses radioactive tracers (radiopharmaceutical) to determine bodily function and to diagnose and treat disease. It is featured with designed camera that allows doctor to track the path of these radioactive trackers. In nuclear medication, Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) are common imaging scanning those are widely used in end-use industry. Nuclear medicine is implemented in human body by injecting radioactive material (radiopharmaceuticals or radiotracers) that can easily be detected on the PET scan. Radiotracers are commonly used in cancer treatment as it contains fluorodeoxyglucose that is a molecule like glucose. Cancer cells are metabolically active and absorb glucose at a higher speed that can easily be detected by PET scans. Therefore, efficient application of Nuclear medicine in cancer detection coupled with rising cancer cases across the globe accelerate the growth of market over the forecast years. For instance: According to the International Agency for Research on Cancer (IARC) 2018, over 17 Billion new cancer cases were registered in 2018. Additionally, increasing incidence and prevalence of target conditioning is the factor driving the growth of market over the upcoming years. Whereas, application of radiopharmaceuticals in neurological disorders is an opportunity for the market growth. However, short life of radiopharmaceuticals are the factors hamper the growth of market over the forecast years.

The regional analysis of global Nuclear Medicine/ Radiopharmaceuticals market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America accounts for the largest share in the global Nuclear Medicine market due to the increased better infrastructure facility in the health care sector. Similarly, North America is the fastest growing region in the market owing to the effectiveness of a diagnosis procedure for the early detection such as cancer and cardiac diseases.

Market player included in this report are:
Cardinal Health
Positron Corporation
GE Healthcare
Curium
Lantheus Medical Imaging
Bayer
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine

By Application:
Diagnostic Application
Therapeutic application
By Procedural Volume:
Diagnostic procedures
Therapeutic procedures

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Nuclear Medicine/ Radiopharmaceuticals Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Nuclear Medicine/ Radiopharmaceuticals Market, by Region, 2017-2026 (USD Billion)
1.2.2. Nuclear Medicine/ Radiopharmaceuticals Market, by Type ,2017-2026 (USD Billion)
1.2.3. Nuclear Medicine/ Radiopharmaceuticals Market, by Application,2017-2026 (USD Billion)
1.2.4. Nuclear Medicine/ Radiopharmaceuticals Market, by Procedural Volume, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Nuclear Medicine/ Radiopharmaceuticals Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Nuclear Medicine/ Radiopharmaceuticals Market Dynamics
3.1. Nuclear Medicine/ Radiopharmaceuticals Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Nuclear Medicine/ Radiopharmaceuticals Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Nuclear Medicine/ Radiopharmaceuticals Market, by Type
5.1. Market Snapshot
5.2. Global Nuclear Medicine/ Radiopharmaceuticals Market by Type, Performance – Potential Analysis
5.3. Global Nuclear Medicine/ Radiopharmaceuticals Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
5.4. Nuclear Medicine/ Radiopharmaceuticals Market, Sub Segment Analysis
5.4.1. Diagnostic Nuclear Medicine
5.4.2. Therapeutic Nuclear Medicine
Chapter 6. Global Nuclear Medicine/ Radiopharmaceuticals Market, by Application
6.1. Market Snapshot
6.2. Global Nuclear Medicine/ Radiopharmaceuticals Market by Application, Performance – Potential Analysis
6.3. Global Nuclear Medicine/ Radiopharmaceuticals Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
6.4. Nuclear Medicine/ Radiopharmaceuticals Market, Sub Segment Analysis
6.4.1. Diagnostic Application
6.4.2. Therapeutic Application
Chapter 7. Global Nuclear Medicine/ Radiopharmaceuticals Market, by Procedural Volume
7.1. Market Snapshot
7.2. Global Nuclear Medicine/ Radiopharmaceuticals Market by Procedural Volume, Performance – Potential Analysis
7.3. Global Nuclear Medicine/ Radiopharmaceuticals Market Estimates & Forecasts by Procedural Volume 2016-2026 (USD Billion)
7.4. Nuclear Medicine/ Radiopharmaceuticals Market, Sub Segment Analysis
7.4.1. Diagnostic procedures
7.4.2. Therapeutic procedures
Chapter 8. Global Nuclear Medicine/ Radiopharmaceuticals Market, Regional Analysis
8.1. Nuclear Medicine/ Radiopharmaceuticals Market, Regional Market Snapshot
8.2. North America Nuclear Medicine/ Radiopharmaceuticals Market
8.2.1. U.S. Nuclear Medicine/ Radiopharmaceuticals Market
8.2.1.1. Type breakdown estimates & forecasts, 2016-2026
8.2.1.2. Application breakdown estimates & forecasts, 2016-2026
8.2.1.3. Procedural Volume breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Nuclear Medicine/ Radiopharmaceuticals Market
8.3. Europe Nuclear Medicine/ Radiopharmaceuticals Market Snapshot
8.3.1. U.K. Nuclear Medicine/ Radiopharmaceuticals Market
8.3.2. Rest of Europe Nuclear Medicine/ Radiopharmaceuticals Market
8.4. Asia-Pacific Nuclear Medicine/ Radiopharmaceuticals Market Snapshot
8.4.1. China Nuclear Medicine/ Radiopharmaceuticals Market
8.4.2. India Nuclear Medicine/ Radiopharmaceuticals Market
8.4.3. Japan Nuclear Medicine/ Radiopharmaceuticals Market
8.4.4. Rest of Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market
8.5. Latin America Nuclear Medicine/ Radiopharmaceuticals Market Snapshot
8.5.1. Brazil Nuclear Medicine/ Radiopharmaceuticals Market
8.5.2. Mexico Nuclear Medicine/ Radiopharmaceuticals Market
8.6. Rest of The World Nuclear Medicine/ Radiopharmaceuticals Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Cardinal Health
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. GE Healthcare
9.2.3. Curium
9.2.4. Lantheus Medical Imaging
9.2.5. Bayer
9.2.6. Bracco Imaging
9.2.7. Eczacibasi-Monrol Nuclear Products
9.2.8. Nordion
9.2.9. Advanced Accelerator Applications
9.2.10. Positron Corporation
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET
TABLE 3. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
TABLE 8. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
TABLE 9. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY PROCEDURAL VOLUME 2016-2026 (USD BILLION)
TABLE 10. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. U.S. NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. U.S. NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 23. CANADA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. CANADA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. CANADA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 26. UK NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 27. UK NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. UK NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 29. GERMANY NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 30. GERMANY NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. GERMANY NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32. ROE NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 33. ROE NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. ROE NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 35. CHINA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 36. CHINA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. CHINA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38. INDIA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 39. INDIA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. INDIA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 41. JAPAN NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 42. JAPAN NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. JAPAN NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44. ROAPAC NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 45. ROAPAC NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. ROAPAC NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47. BRAZIL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 48. BRAZIL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. BRAZIL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. MEXICO NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 51. MEXICO NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. MEXICO NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53. ROLA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 54. ROLA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROLA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. ROW NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 57. ROW NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 58. ROW NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

FIG 1. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, KEY TRENDS 2018
FIG 5. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, GROWTH PROSPECTS 2019-2026
FIG 6. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, PEST ANALYSIS
FIG 8. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLION)
FIG 16. EUROPE NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLION)
FIG 17. ASIA PACIFIC NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLION)
FIG 18. LATIN AMERICA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLION)
FIG 19. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, COMPANY MARKET SHARE ANALYSIS (2018)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[核医学/放射性医薬品の世界市場:種類別(診断核医学、治療核医学)、用途別(診断用、治療用)、処置別(診断、治療)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆